259 related articles for article (PubMed ID: 25533197)
21. Plasma metabolic alterations in patients with severe obesity and non-alcoholic steatohepatitis.
Cabré N; Luciano-Mateo F; Baiges-Gayà G; Fernández-Arroyo S; Rodríguez-Tomàs E; Hernández-Aguilera A; París M; Sabench F; Del Castillo D; López-Miranda J; Menéndez JA; Camps J; Joven J
Aliment Pharmacol Ther; 2020 Feb; 51(3):374-387. PubMed ID: 31825539
[TBL] [Abstract][Full Text] [Related]
22. Circulating PCSK9 levels are not associated with the severity of hepatic steatosis and NASH in a high-risk population.
Wargny M; Ducluzeau PH; Petit JM; Le May C; Smati S; Arnaud L; Pichelin M; Bouillet B; Lannes A; Blanchet O; Lefebvre P; Francque S; Van Gaal L; Staels B; Vergès B; Boursier J; Cariou B
Atherosclerosis; 2018 Nov; 278():82-90. PubMed ID: 30261472
[TBL] [Abstract][Full Text] [Related]
23. Adiponectin and its receptors in non-alcoholic steatohepatitis.
Kaser S; Moschen A; Cayon A; Kaser A; Crespo J; Pons-Romero F; Ebenbichler CF; Patsch JR; Tilg H
Gut; 2005 Jan; 54(1):117-21. PubMed ID: 15591515
[TBL] [Abstract][Full Text] [Related]
24. Fatty liver disease: predictors of nonalcoholic steatohepatitis and gallbladder disease in morbid obesity.
Liew PL; Lee WJ; Wang W; Lee YC; Chen WY; Fang CL; Huang MT
Obes Surg; 2008 Jul; 18(7):847-53. PubMed ID: 18459024
[TBL] [Abstract][Full Text] [Related]
25. IL-6 and IGF-1 are independent prognostic factors of liver steatosis and non-alcoholic steatohepatitis in morbidly obese patients.
García-Galiano D; Sánchez-Garrido MA; Espejo I; Montero JL; Costán G; Marchal T; Membrives A; Gallardo-Valverde JM; Muñoz-Castañeda JR; Arévalo E; De la Mata M; Muntané J
Obes Surg; 2007 Apr; 17(4):493-503. PubMed ID: 17608262
[TBL] [Abstract][Full Text] [Related]
26. SFRP5 hepatic expression is associated with non-alcoholic liver disease in morbidly obese women.
Gutiérrez-Vidal R; Vega-Badillo J; Reyes-Fermín LM; Hernández-Pérez HA; Sánchez-Muñoz F; López-Álvarez GS; Larrieta-Carrasco E; Fernández-Silva I; Méndez-Sánchez N; Tovar AR; Villamil-Ramírez H; Mejía-Domínguez AM; Villarreal-Molina T; Hernández-Pando R; Campos-Pérez F; Aguilar-Salinas CA; Canizales-Quinteros S
Ann Hepatol; 2015; 14(5):666-74. PubMed ID: 26256895
[TBL] [Abstract][Full Text] [Related]
27. Prediction of Nonalcoholic Fatty Liver Disease Via a Novel Panel of Serum Adipokines.
Jamali R; Arj A; Razavizade M; Aarabi MH
Medicine (Baltimore); 2016 Feb; 95(5):e2630. PubMed ID: 26844476
[TBL] [Abstract][Full Text] [Related]
28. Hepatic miR-33a/miR-144 and their target gene ABCA1 are associated with steatohepatitis in morbidly obese subjects.
Vega-Badillo J; Gutiérrez-Vidal R; Hernández-Pérez HA; Villamil-Ramírez H; León-Mimila P; Sánchez-Muñoz F; Morán-Ramos S; Larrieta-Carrasco E; Fernández-Silva I; Méndez-Sánchez N; Tovar AR; Campos-Pérez F; Villarreal-Molina T; Hernández-Pando R; Aguilar-Salinas CA; Canizales-Quinteros S
Liver Int; 2016 Sep; 36(9):1383-91. PubMed ID: 26945479
[TBL] [Abstract][Full Text] [Related]
29. Hepatic histopathology of morbid obesity: concurrence of other forms of chronic liver disease.
Liew PL; Lee WJ; Lee YC; Wang HH; Wang W; Lin YC
Obes Surg; 2006 Dec; 16(12):1584-93. PubMed ID: 17217634
[TBL] [Abstract][Full Text] [Related]
30. [Relationship between morphological diagnosis of NASH (non-alcoholic steatohepatitis) and liver function tests in a group of patients with morbid obesity].
Chavarría-Arciniega S; López-Alvarenga JC; Uribe-Uribe NO; Herrera-Hernández M; González-Barranco J
Rev Invest Clin; 2005; 57(4):505-12. PubMed ID: 16315634
[TBL] [Abstract][Full Text] [Related]
31. Endocannabinoid receptors gene expression in morbidly obese women with nonalcoholic fatty liver disease.
Auguet T; Berlanga A; Guiu-Jurado E; Terra X; Martinez S; Aguilar C; Filiu E; Alibalic A; Sabench F; Hernández M; Del Castillo D; Richart C
Biomed Res Int; 2014; 2014():502542. PubMed ID: 24864249
[TBL] [Abstract][Full Text] [Related]
32. PNPLA3 Expression Is Related to Liver Steatosis in Morbidly Obese Women with Non-Alcoholic Fatty Liver Disease.
Aragonès G; Auguet T; Armengol S; Berlanga A; Guiu-Jurado E; Aguilar C; Martínez S; Sabench F; Porras JA; Ruiz MD; Hernández M; Sirvent JJ; Del Castillo D; Richart C
Int J Mol Sci; 2016 Apr; 17(5):. PubMed ID: 27128907
[TBL] [Abstract][Full Text] [Related]
33. Expression of adiponectin and its receptors in livers of morbidly obese patients with non-alcoholic fatty liver disease.
Ma H; Gomez V; Lu L; Yang X; Wu X; Xiao SY
J Gastroenterol Hepatol; 2009 Feb; 24(2):233-7. PubMed ID: 18713296
[TBL] [Abstract][Full Text] [Related]
34. Lipoprotein subclass metabolism in nonalcoholic steatohepatitis.
Männistö VT; Simonen M; Soininen P; Tiainen M; Kangas AJ; Kaminska D; Venesmaa S; Käkelä P; Kärjä V; Gylling H; Ala-Korpela M; Pihlajamäki J
J Lipid Res; 2014 Dec; 55(12):2676-84. PubMed ID: 25344588
[TBL] [Abstract][Full Text] [Related]
35. Increased Cardiac Uptake of Ketone Bodies and Free Fatty Acids in Human Heart Failure and Hypertrophic Left Ventricular Remodeling.
Voros G; Ector J; Garweg C; Droogne W; Van Cleemput J; Peersman N; Vermeersch P; Janssens S
Circ Heart Fail; 2018 Dec; 11(12):e004953. PubMed ID: 30562098
[TBL] [Abstract][Full Text] [Related]
36. Activities of enzymes of fat and ketone-body metabolism and effects of starvation on blood concentrations of glucose and fat fuels in teleost and elasmobranch fish.
Zammit VA; Newsholme EA
Biochem J; 1979 Nov; 184(2):313-22. PubMed ID: 534530
[TBL] [Abstract][Full Text] [Related]
37. GDF11 induces mild hepatic fibrosis independent of metabolic health.
Frohlich J; Kovacovicova K; Mazza T; Emma MR; Cabibi D; Foti M; Sobolewski C; Oben JA; Peyrou M; Villarroya F; Soresi M; Rezzani R; Cervello M; Bonomini F; Alisi A; Vinciguerra M
Aging (Albany NY); 2020 Oct; 12(20):20024-20046. PubMed ID: 33126224
[TBL] [Abstract][Full Text] [Related]
38. Limited utility of plasma M30 in discriminating non-alcoholic steatohepatitis from steatosis--a comparison with routine biochemical markers.
Chan WK; Sthaneshwar P; Nik Mustapha NR; Mahadeva S
PLoS One; 2014; 9(9):e105903. PubMed ID: 25184298
[TBL] [Abstract][Full Text] [Related]
39. Oral beta-hydroxybutyrate supplementation in two patients with hyperinsulinemic hypoglycemia: monitoring of beta-hydroxybutyrate levels in blood and cerebrospinal fluid, and in the brain by in vivo magnetic resonance spectroscopy.
Plecko B; Stoeckler-Ipsiroglu S; Schober E; Harrer G; Mlynarik V; Gruber S; Moser E; Moeslinger D; Silgoner H; Ipsiroglu O
Pediatr Res; 2002 Aug; 52(2):301-6. PubMed ID: 12149510
[TBL] [Abstract][Full Text] [Related]
40. Plasma Pentraxin 3 Differentiates Nonalcoholic Steatohepatitis (NASH) from Non-NASH.
Boga S; Koksal AR; Alkim H; Yilmaz Ozguven MB; Bayram M; Ergun M; Sisman G; Tekin Neijmann S; Alkim C
Metab Syndr Relat Disord; 2015 Nov; 13(9):393-9. PubMed ID: 26367098
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
